| DGAP Voting Rights Announcement: STADA Arzneimittel AG STADA Arzneimittel AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution 22.10.2018 / 14:41 Dissemination of a Voting Rights Announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.
Notification of Major Holdings 1. Details of issuer | STADA Arzneimittel AG Stadastraße 2-18 61118 Bad Vilbel Germany | 2. Reason for notification | | Acquisition/disposal of shares with voting rights | | | Acquisition/disposal of instruments | | | Change of breakdown of voting rights | | X | Other reason: Lapse of financial instruments due to the tendering of shares into the delisting tender offer by certain shareholders pursuant to irrevocable undertaking | 3. Details of person subject to the notification obligation | Name: | City and country of registered office: | | Bain Capital Investors, LLC | Wilmington, Delaware United States of America (USA) | 4. Names of shareholder(s) holding directly 3% or more voting rights, if different from 3. 5. Date on which threshold was crossed or reached:6. Total positions | | % of voting rights attached to shares (total of 7.a.) | % of voting rights through instruments (total of 7.b.1 + 7.b.2) | total of both in % (7.a. + 7.b.) | total number of voting rights of issuer | | Resulting situation | 65.31 % | 7.08 % | 72.39 % | 62,342,440 | | Previous notification | 65.31 % | 12.06 % | 77.38 % | / | 7. Notified details of the resulting situation a. Voting rights attached to shares (Sec.s 33, 34 WpHG) | ISIN | absolute | in % | | | direct (Sec. 33 WpHG) | indirect (Sec. 34 WpHG) | direct (Sec. 33 WpHG) | indirect (Sec. 34 WpHG) | | DE0007251803 | | 40,716,644 | % | 65.31 % | | Total | 40,716,644 | 65.31 % | b.1. Instruments according to Sec. 38 para. 1 No. 1 WpHG | Type of instrument | Expiration or maturity date | Exercise or conversion period | Voting rights absolute | Voting rights in % | | Tender under domination and profit and loss transfer agreement | n/a | n/a | 491 | 0.0008 % | | | | Total | 491 | 0.0008 % | b.2. Instruments according to Sec. 38 para. 1 No. 2 WpHG | Type of instrument | Expiration or maturity date | Exercise or conversion period | Cash or physical settlement | Voting rights absolute | Voting rights in % | | Irrevocable/ purchase option | n/a | n/a | Physical | 4,414,823 | 7.08 % | | | | | Total | 4,414,823 | 7.08 % | 8. Information in relation to the person subject to the notification obligation | | Person subject to the notification obligation is not controlled and does itself not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer (1.). | | X | Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity: | | Name | % of voting rights (if at least held 3% or more) | % of voting rights through instruments (if at least held 5% or more) | Total of both (if at least held 5% or more) | | Bain Capital Investors, LLC | % | % | % | | Bain Capital Partners Europe IV, L.P. | % | % | % | | Bain Capital Europe Fund IV, L.P. | % | % | % | | Universe Luxembourg S.C.A. | % | % | % | | Nidda Topco S.à r.l. | % | % | % | | Nidda Midco S.à r.l | % | % | % | | Nidda German Topco GmbH | % | % | % | | Nidda German Midco GmbH | % | % | % | | Nidda BondCo GmbH | % | % | % | | Nidda Healthcare Holding GmbH | % | % | % | | Nidda Healthcare GmbH | 65.31 % | 7.08 % | 72.39 % | | | | | | | Bain Capital Investors, LLC | % | % | % | | Bain Capital Partners Europe IV, L.P. | % | % | % | | Bain Capital Europe Fund IV, L.P. | % | % | % | | Universe Luxembourg GP S.à r.l. | % | % | % | | Universe Luxembourg S.C.A. | % | % | % | | Nidda Topco S.à r.l | % | % | % | | Nidda Midco S.à r.l | % | % | % | | Nidda German Topco GmbH | % | % | % | | Nidda German Midco GmbH | % | % | % | | Nidda BondCo GmbH | % | % | % | | Nidda Healthcare Holding GmbH | % | % | % | | Nidda Healthcare GmbH | 65.31 % | 7.08 % | 72.39 % | | | | | | | Bain Capital Investors, LLC | % | % | % | | Bain Capital Partners XI, L.P. | % | % | % | | Bain Capital Fund XI, L.P. | % | % | % | | Universe Luxembourg S.C.A. | % | % | % | | Nidda Topco S.à r.l. | % | % | % | | Nidda Midco S.à r.l | % | % | % | | Nidda German Topco GmbH | % | % | % | | Nidda German Midco GmbH | % | % | % | | Nidda BondCo GmbH | % | % | % | | Nidda Healthcare Holding GmbH | % | % | % | | Nidda Healthcare GmbH | 65.31 % | 7.08 % | 72.39 % | 9. In case of proxy voting according to Sec. 34 para. 3 WpHG | Date of general meeting: | | | Holding position after general meeting: | % (equals voting rights) | 10. Other explanatory remarks:
22.10.2018 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de
|
